Background:Venous thromboembolism is a significant healthcare problem, with an estimated 900,000 cases of VT and Pulmonary Embolism, causing 300,00 deaths yearly.[1]VTE is one of the most common vascular diseases associated with high morbidity rate,which is an acute event complicating 2–3/1000 hospital admissions followed by principal diagnosis.[2] Aims and objectives: • To assess the epidemiology, aetiology and treatment options for DVT. • To assess the incidence of anaemia in patients with DVT. Methodology:All patients admitted in the vascular surgery wards of SJICSR with the diagnosis of deep vein thrombosis from July 2023 to June 2024, were retrospectively analysed in terms of age, sex, risk factor, association with anaemia, laboratory factors, site affected, complications and the mode of treatment–medical/thrombolysis/IVC filter. Results:Mean age – 45.59 years, with minimum was 17 and the maximum was 84 years. Male preponderance noted. 53.7% of the cases underlying risk factor could not be identified, 11.9% patients suffered from trauma. 45.5% patients found to have anaemia. Lower limb affected more commonly than upper limb.8.2% presented with pulmonary embolism, other cases were uncomplicated. 85.8% of the cases could be managed conservatively. Conclusions: VTE is a disease of the middle age, equally distributed among male and female, lower limb affected more and conservative management remains the mainstay of treatment, commonly associated with anaemia.IVC filters – retrievable, remained the main treatment modality in those who have developed DVT following trauma, or have a scheduled surgery in the near future.